June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Serum protein analysis of patients with different vitreoretinal diseases by means of antibody microarrays
Author Affiliations & Notes
  • Christina Korb
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Sabine Beck
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Katrin Lorenz
    Department of Ophthalmology, University Medical Center, Mainz, Germany
  • Alireza Mirshahi
    Department of Ophthalmology, University Medical Center, Mainz, Germany
  • Bernhard Stoffelns
    Department of Ophthalmology, University Medical Center, Mainz, Germany
  • Norbert Pfeiffer
    Department of Ophthalmology, University Medical Center, Mainz, Germany
  • Franz Grus
    Experimental Ophthalmology, University Medical Center, Mainz, Germany
  • Footnotes
    Commercial Relationships Christina Korb, None; Sabine Beck, None; Katrin Lorenz, Sensimed AG (F), Sensimed AG (R), MSD (R), Ivantis Inc (F), Ivantis Inc (R), Bayer (R); Alireza Mirshahi, None; Bernhard Stoffelns, None; Norbert Pfeiffer, Sensimed AG (F), Sensimed AG (R), MSD (F), MSD (R), Alcon (F), Allergan (F), Novartis (F), Novartis (R), Bayer (F), Heidelberg Engineering (F), Bausch&Lomb (F), Boehringer-Ingelheim (F), Carl Zeiss Meditech (F), Chibret (F), Nidek (F), Pfizer (F), Santen (F), Santen (R), Topcon (F), Ivantis Inc (F), Ivantis Inc (R); Franz Grus, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3332. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christina Korb, Sabine Beck, Katrin Lorenz, Alireza Mirshahi, Bernhard Stoffelns, Norbert Pfeiffer, Franz Grus; Serum protein analysis of patients with different vitreoretinal diseases by means of antibody microarrays. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3332.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To develop a comparative proteome analysis of human serum samples in patients with various vitreoretinal diseases to provide insights into factors and mechanisms responsible for these diseases.

Methods: Serum samples were collected from 63 patients with macular pucker (n=19), idiopathic macular hole (n=16), proliferative diabetic retinopathy (DR, n=10), rhegmatogenous (n=6) or tractional (n=9) retinal detachment and neovascular age-related macular degeneration (AMD, n=3). As control group, serum samples from 27 healthy subjects were used. Protein expression levels were estimated using customized antibody microarrays. The 29 spotted antibodies represented families of proteins known to be involved in a variety of important biological pathways, including heat shock proteins (HSPs), proteins of the complement pathway and cytokines. Emitted fluorescence signals were digitized and spot intensities were compared to estimate changes in protein expression.

Results: Complex patterns of proteins could be detected in all clinical groups. Furthermore, differences in mean protein intensity could be detected in all diseases in comparison to the control cohort. Mean intensities of some proteins, e.g. Interleukin 2, HSP 27, and Protein S100A8 were lower in serum in all clinical groups compared controls. Some of the detected protein levels were about 3 fold higher in only some clinical groups , for example PEDF: > 3.6 change in AMD or Il-1-beta: > 2.8 in DR. With respect to the control subjects with no ocular disease, protein abundance of complement protein C9, HSP 90 and HSP 70 was lower in serum especially in the group of patients with neovascular age-related macular degeneration (protein expression in patients compared to controls is decreased about 50%).

Conclusions: Our study provides a proteomic analysis of the serum proteome and reveals protein alterations in the included clinical groups compared to the group of healthy subjects. Each vitreoretinal disease altered a unique set of proteins. These potential biomarkers could lead to new insights in underlying pathomechanisms of the analyzed diseases.

Keywords: 663 proteomics • 688 retina • 762 vitreoretinal surgery  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×